5 Lung Cancer Clinical Trials in Saraland, AL (2026)

Q: How do I join a clinical trial in Saraland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Saraland research site will contact you.

Recruiting Lung Cancer Studies in Saraland

NCT03851445Recruiting

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to ...

Saraland, ALPHASE210,000 participantsSWOG Cancer Research Network

View Study Details

NCT05624996Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by ...

Saraland, ALPHASE3474 participantsNRG Oncology

View Study Details

NCT06616584Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

This phase II/III Expanded Lung-MAP treatment trial compares the effect of adding cemiplimab to docetaxel and ramucirumab versus docetaxel and ramucirumab alone in treating patients with non-small cel...

Saraland, ALPHASE2378 participantsSWOG Cancer Research Network

View Study Details

NCT05642572Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread fr...

Saraland, ALPHASE266 participantsSWOG Cancer Research Network

View Study Details

NCT06031688Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first s...

Saraland, ALPHASE256 participantsSWOG Cancer Research Network

View Study Details

About Lung Cancer Clinical Trials in Saraland

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Saraland, AL. These studies are seeking a combined 10,974 participants. Research is being sponsored by SWOG Cancer Research Network, NRG Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Saraland — FAQ

Are there lung cancer clinical trials in Saraland?

Yes, there are 5 lung cancer clinical trials currently recruiting in Saraland, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Saraland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Saraland research site will contact you about next steps.

Are clinical trials in Saraland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Saraland studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Saraland are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 23, 2026 from ClinicalTrials.gov